Authentidate to Discuss Merger With AEON, Introduce New Senior Management, in Conference Call on Tuesday, February 2, 2016
29 Gennaio 2016 - 8:29PM
Authentidate Holding Corp. (Nasdaq:ADAT) today announced that it
plans to host a conference call on Tuesday, February 2, 2016, at
12:00 p.m. ET, to discuss the company’s recently completed merger
transaction whereby privately-held AEON has merged with a
wholly-owned subsidiary of Authentidate, creating a company focused
on delivering innovative solutions that achieve technology best
practices in medicine and raise the standard of healthcare. The
call will be hosted by Richard Hersperger, the Company’s new Chief
Executive Officer, and Mr. Hersperger will take questions from
investors.
The dial-in number for callers in the U.S. is 877-407-8293 and
the dial in number for international callers is 201-689-8349. Or,
participants may access a live webcast of the conference call by
clicking the link listed on Authentidate’s Investor Events Page at
URL:
http://www.authentidate.com/investors/investor-events
A dial-in replay of the call will be available through February
16, 2016. To access the replay, please dial 877-660-6853 in the
U.S. and 201-612-7415 internationally, and enter the conference ID
# 13629758. A link to replay the webcast of the conference call
will be listed on Authentidate’s Investor Events &
Presentations page
at http://www.authentidate.com/investors/investor-events
Additional information regarding the merger, including updated
financial information, will be filed before the call in
Authentidate’s Form 8-K, filed with the Securities and Exchange
Commission, copies of which are available
at www.sec.gov or at www.authentidate.com under
the SEC filings tab located on the Investor Relations page.
About AEON Clinical Laboratories
AEON Clinical Laboratories is a growing comprehensive and
efficient clinical laboratory using state of the art testing
equipment. Housed in a 28,000 square foot campus, in Gainesville,
Georgia, AEON emphasizes Technology Innovation. AEON has developed
proprietary methodologies that provide some of the fastest and most
reliable urine and oral fluid (saliva) test results in the nation.
AEON provides health care professionals with four primary tests:
Medical Toxicology, Pharmacogenomics, Cancer Genetic Testing, and
Molecular Biology.
About Authentidate Holding Corp.
Authentidate Holding Corp. is a provider of secure web-based
revenue cycle management applications and telehealth products and
services that enable healthcare organizations to coordinate care
for patients and enhance related administrative and clinical
workflows. Authentidate’s products and services enable healthcare
organizations to increase revenues, reduce costs and enhance
patient care by eliminating paper and manual work steps from
clinical and administrative processes. Authentidate’s telehealth
solutions combine patient vital signs monitoring with a web
application that streamlines patient care management. Delivered as
Software as a Service (SaaS), customers only require an Internet
connection and web browser to access our web-based applications
thereby utilizing previous investments in systems and technology.
The Company’s healthcare customers and users include leading
homecare companies, health systems, physician groups and
governmental entities. These organizations utilize the Company’s
products and services to coordinate care for patients outside of
acute-care.
Authentidate, Inscrybe and InscrybeMD are registered trademarks
of Authentidate Holding Corp. All other trade names are the
property of their respective owners.
For more information, visit the company’s website
at www.authentidate.com
This press release contains forward-looking statements within
the meaning of section 27A of the Securities Act of 1933 and
section 21E of the Securities Act of 1934. When used in this
release, the words “believe,” “anticipate,” “think,” “intend,”
“plan,” “will be,” “expect,” and similar expressions identify such
forward-looking statements. Such statements regarding future events
and/or the future financial performance of the company are subject
to certain risks and uncertainties, which could cause actual events
or the actual future results of the company to differ materially
from any forward-looking statement. Such risks and uncertainties
include, among other things, the availability of any needed
financing, the company’s ability to implement its business plan for
various applications of its technologies, the impact of
competition, the management of growth, and the other risks and
uncertainties that may be detailed from time to time in the
company’s reports filed with the Securities and Exchange
Commission. In light of the significant risks and uncertainties
inherent in the forward-looking statements included herein, the
inclusion of such statements should not be regarded as a
representation by the company or any other person that the
objectives and plans of the company will be achieved.
Authentidate Contacts:
James Carbonara, Hayden IR,
james@haydenir.com or (646) 755-7412
Brett Maas, Hayden IR,
Brett@haydenir.com or (646) 536-7331
Grafico Azioni Aeon Global Health (CE) (USOTC:AGHC)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Aeon Global Health (CE) (USOTC:AGHC)
Storico
Da Giu 2023 a Giu 2024